Join Eli Lilly and the Tri-State Obesity Society (TriOS) for a live webinar designed for obesity medicine clinicians interested in the evolving role of orforglipron. This session will include clinician-focused data review, practical prescribing insights, and an interactive Q&A.

Co-hosted by TriOS's Vice President, Devika Umashanker, MD, MS, MBA who is a board-certified obesity medicine specialist and the System Director of Medical Weight Loss at the Hartford HealthCare Digestive Health Institute. She specializes in bariatric and obesity medicine and serves patients through Hartford HealthCare Medical & Surgical Weight Loss in Glastonbury, Connecticut. Dr. Umashanker completed her medical degree at the American University of the Caribbean, trained in internal medicine at Yale, and completed fellowship training in Obesity Medicine at Weill Cornell Medical College